Business Description
CytoMed Therapeutics Ltd
ISIN : SGXZ17669631
Description
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.1 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -35.5 | |||||
| 3-Year EPS without NRI Growth Rate | -26.6 | |||||
| 3-Year FCF Growth Rate | -48.1 | |||||
| 3-Year Book Growth Rate | 181 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.14 | |||||
| 9-Day RSI | 49.13 | |||||
| 14-Day RSI | 48.29 | |||||
| 6-1 Month Momentum % | -47.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.09 | |||||
| Quick Ratio | 14.09 | |||||
| Cash Ratio | 12.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.8 | |||||
| Shareholder Yield % | -24.27 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -49.62 | |||||
| ROA % | -39.41 | |||||
| ROIC % | -92.32 | |||||
| ROC (Joel Greenblatt) % | -151.79 | |||||
| ROCE % | -46.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.91 | |||||
| Price-to-Tangible-Book | 2.91 | |||||
| EV-to-EBIT | -5.96 | |||||
| EV-to-EBITDA | -6.58 | |||||
| EV-to-FCF | -7.01 | |||||
| Price-to-Net-Current-Asset-Value | 3.71 | |||||
| Price-to-Net-Cash | 4.2 | |||||
| Earnings Yield (Greenblatt) % | -16.77 | |||||
| FCF Yield % | -10.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CytoMed Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.268 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 48.29 | ||
| 14-Day ATR (€) | 0.065651 | ||
| 20-Day SMA (€) | 1.9025 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 1.78 - 3.82 | ||
| Shares Outstanding (Mil) | 11.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CytoMed Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CytoMed Therapeutics Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CytoMed Therapeutics Ltd Frequently Asked Questions
What is CytoMed Therapeutics Ltd(FRA:F98)'s stock price today?
The current price of FRA:F98 is €1.89. The 52 week high of FRA:F98 is €3.82 and 52 week low is €1.78.
When is next earnings date of CytoMed Therapeutics Ltd(FRA:F98)?
The next earnings date of CytoMed Therapeutics Ltd(FRA:F98) is 2024-05-31 Est..
Does CytoMed Therapeutics Ltd(FRA:F98) pay dividends? If so, how much?
CytoMed Therapeutics Ltd(FRA:F98) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers